Proof-of-principle experiments during beamline technical commissioning

Beamline 23-ID-B,
March 2025

On March 11, 2025, we began scientific commissioning. During the APS shutdown to replace the storage ring, we also rebuilt the GM/CA beamlines. The X-ray beam is very small and extremely bright!

 

Beamline 23-ID-B,
December 2024

On November 25, 2024, we received permission to begin technical commissioning of the new optics and endstation instruments with X-rays for GM/CA@APS beamlines. Technical commissioning of beamline 23-ID-B began immediately. An intense, focused sub-micron beam was achieved, and before the APS shutdown (December 19 - January 26), we began testing as many components as possible. Just before the shutdown, we performed "heroic" experiments under manual conditions and obtained high-quality electron-density maps (see below). The current focus is on transitioning from these proof-of-principle experiments to user-friendly beamline operability as soon as possible. This is a complex process because we replaced many outdated or end-of-life components on the beamline, including the focusing optics, the beam-delivery system, the goniometry, and the low-level hardware and software that drives all motions on the beamline and the data acquisition system. See this website for future announcements.

Figure: Left: trypsin (1.0-Å resolution, 50µm beam, 20 keV X-rays). Right: crambin (0.7-Å resolution, 1µm beam, 20 keV X-rays). 2Fo-Fc density (blue) is contoured at 1.0 σ for trypsin and 1.5 σ for crambin, and Fo-Fc density at 3 σ for both in green (+) and red (-).
The trypsin sample was from Palani Kandavelu (SER-CAT) and the crambin sample was from Julian Chen, Changsoo Chang, and Andrzej Joachimiak (SBC).

 

 

 


GM/CA @ APS Sponsors: National Institute of General Medical Sciences (NIGMS) and National Cancer Institute (NCI) of the National Institutes of Health (NIH).

  GM/CA @ APS is an Office of Science User Facility operated for the U.S. Department of Energy by Argonne National Laboratory

  UChicago Argonne LLC | Privacy & Security Notice | Contact Us | A-Z Index | Search